The Estimated Glomerular Filtration Rate in the Prediction of Major Adverse Cardiovascular Events in Patients with Normal Renal Function after Coronary Artery Bypass Grafting: A Single-Center Retrospective Cohort Study
DOI:
https://doi.org/10.59958/hsf.8013Keywords:
estimated glomerular filtration rate, major adverse cardiovascular events, coronary artery bypass graftingAbstract
Background: The estimated glomerular filtration rate (eGFR) has emerged as a risk factor for coronary artery disease (CAD), but there are currently insufficient data on the association of eGFR with the postoperative prognosis in patients undergoing coronary artery bypass grafting (CABG). This study aimed to investigate the potential utility of eGFR as a prognostic indicator for major adverse cardiovascular events (MACE) in patients with normal renal function after CABG. Methods: This study included a total of 222 consecutive patients with normal renal function (eGFR ≥90 mL/min/1.73 m2) who underwent CABG between June 2018 and December 2019. These patients were divided into two groups based on the occurrence of MACE: without MACE group (n = 202) and with MACE group (n = 20). The eGFR was calculated from serum creatinine (SCr). The eGFR (mL/min/1.73 m2) = 175 × SCr (mg/dL)–1.234 × age (year)–0.179 × 0.79 (in the case of females). Kaplan–Meier survival curve analysis was conducted followed by the log-rank test. Cox proportional hazards regression models were used to explore the association between the eGFR and MACE. Receiver operating characteristics (ROC) curve analysis was performed to assess the predictive performance of the eGFR and identify the optimal cutoff point. Results: A progressively lower eGFR was associated with an increasingly higher cumulative incidence of MACE (log-rank test, p = 0.017). The hazard ratio (95% CI) of MACE was 0.068 (0.005–0.941) in tertile 3 of the eGFR and 0.204 (0.051–0.817) per SD increase in the eGFR. The AUC of the eGFR was 0.678 (p = 0.009) and the optimal cut-off value to predict MACE was >118.3 mL/min/1.73 m2. Conclusion: The eGFR may be an independent prognostic determinant in patients with normal renal function undergoing CABG surgery. In patients with normal renal function, MACE was more likely to occur in patients with lower eGFR compared with those with higher eGFR. The eGFR may have an important predictive value in predicting MACE in patients with normal renal function undergoing CABG surgery.
References
GBD 2021 Risk Factors Collaborators. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet (London, England). 2024; 403: 2162–2203.
Correction to: 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association. Circulation. 2024; 149: e1164.
Corrigendum to: 2018 ESC/EACTS Guidelines on myocardial revascularization. European Heart Journal. 2019; 40: 3096.
Andrade PJND, Medeiros MMDC, Andrade ATD, Lima AAG. Coronary angioplasty versus CABG: review of randomized trials. Arquivos Brasileiros De Cardiologia. 2011; 97: e60–e69.
Letsou GV, Musfee FI, Zhang Q, Loor G, Lee AD. Stroke and mortality rates after off-pump vs. pump-assisted/no-clamp coronary artery bypass grafting. The Journal of Cardiovascular Surgery. 2022; 63: 742–748.
Montrief T, Koyfman A, Long B. Coronary artery bypass graft surgery complications: A review for emergency clinicians. The American Journal of Emergency Medicine. 2018; 36: 2289–2297.
Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic kidney disease: global dimension and perspectives. Lancet (London, England). 2013; 382: 260–272.
Stevens PE, Levin A, Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Annals of Internal Medicine. 2013; 158: 825–830.
Murton M, Goff-Leggett D, Bobrowska A, Garcia Sanchez JJ, James G, Wittbrodt E, et al. Burden of Chronic Kidney Disease by KDIGO Categories of Glomerular Filtration Rate and Albuminuria: A Systematic Review. Advances in Therapy. 2021; 38: 180–200.
Sarnak MJ, Amann K, Bangalore S, Cavalcante JL, Charytan DM, Craig JC, et al. Chronic Kidney Disease and Coronary Artery Disease: JACC State-of-the-Art Review. Journal of the American College of Cardiology. 2019; 74: 1823–1838.
Tonelli M, Muntner P, Lloyd A, Manns BJ, Klarenbach S, Pannu N, et al. Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study. Lancet (London, England). 2012; 380: 807–814.
Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. New England Journal of Medicine. 2004; 351: 1296–1305.
Go AS, Bansal N, Chandra M, Lathon PV, Fortmann SP, Iribarren C, et al. Chronic kidney disease and risk for presenting with acute myocardial infarction versus stable exertional angina in adults with coronary heart disease. Journal of the American College of Cardiology. 2011; 58: 1600–1607.
De Luca L, Di Pasquale G, Gonzini L, Uguccioni M, Olivari Z, Casella G, et al. Temporal Trends in Invasive Management and In-Hospital Mortality of Patients With Non-ST Elevation Acute Coronary Syndromes and Chronic Kidney Disease. Angiology. 2021; 72: 236–243.
Chen J, Budoff MJ, Reilly MP, Yang W, Rosas SE, Rahman M, et al. Coronary Artery Calcification and Risk of Cardiovascular Disease and Death Among Patients With Chronic Kidney Disease. JAMA Cardiology. 2017; 2: 635–643.
Chronic Kidney Disease Prognosis Consortium, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet (London, England). 2010; 375: 2073–2081.
Joosen IA, Schiphof F, Versteylen MO, Laufer EM, Winkens MH, Nelemans PJ, et al. Relation between mild to moderate chronic kidney disease and coronary artery disease determined with coronary CT angiography. PloS One. 2012; 7: e47267.
Szummer K, Lundman P, Jacobson SH, Schön S, Lindbäck J, Stenestrand U, et al. Influence of renal function on the effects of early revascularization in non-ST-elevation myocardial infarction: data from the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART). Circulation. 2009; 120: 851–858.
Reinecke H, Trey T, Matzkies F, Fobker M, Breithardt G, Schaefer RM. Grade of chronic renal failure, and acute and long-term outcome after percutaneous coronary interventions. Kidney International. 2003; 63: 696–701.
Kim TO, Kang DY, Ahn JM, Kim SO, Lee PH, Lee J, et al. Prognostic Impact of Mildly Impaired Renal Function in Patients Undergoing Multivessel Coronary Revascularization. Journal of the American College of Cardiology. 2022; 79: 1270–1284.
Hong S, Han K, Park CY. The triglyceride glucose index is a simple and low-cost marker associated with atherosclerotic cardiovascular disease: a population-based study. BMC Medicine. 2020; 18: 361.
Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007; 115: 2344–2351.
Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. Journal of the American Society of Nephrology. 2006; 17: 2937–2944.
Fourth universal definition of myocardial infarction (2018). Revista Espanola De Cardiologia (English Ed.). 2019; 72: 72.
Gueugnon M, Stapley PJ, Gouteron A, Lecland C, Morisset C, Casillas JM, et al. Age-Related Adaptations of Lower Limb Intersegmental Coordination During Walking. Frontiers in Bioengineering and Biotechnology. 2019; 7: 173.
Piscitelli P, D’Errico MM, Mirijello A, Santoliquido M, Salvatori M, Vigna C, et al. Low GFR amplifies the association between coronary three-vessel disease and all-cause mortality. Nutrition, Metabolism, and Cardiovascular Diseases: NMCD. 2022; 32: 402–409.
Manjunath G, Tighiouart H, Ibrahim H, MacLeod B, Salem DN, Griffith JL, et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. Journal of the American College of Cardiology. 2003; 41: 47–55.
Ataklte F, Song RJ, Upadhyay A, Musa Yola I, Vasan RS, Xanthakis V. Association of Mildly Reduced Kidney Function With Cardiovascular Disease: The Framingham Heart Study. Journal of the American Heart Association. 2021; 10: e020301.
Ortiz A, Wanner C, Gansevoort R, ERA Council. Chronic kidney disease as cardiovascular risk factor in routine clinical practice: a position statement by the Council of the European Renal Association. Clinical Kidney Journal. 2022; 16: 403–407.
Hou L, Zhao J, He T, Su K, Li Y. Machine Learning-Based Prediction of In-Stent Restenosis Risk Using Systemic Inflammation Aggregation Index Following Coronary Stent Placement. Risk Management and Healthcare Policy. 2024; 17: 1779–1786.
Chen K, Li S, Xie Z, Liu Y, Li Y, Mai J, et al. Association between oxidative balance score, systemic inflammatory response index, and cardiovascular disease risk: a cross-sectional analysis based on NHANES 2007-2018 data. Frontiers in Nutrition. 2024; 11: 1374992.
Rackley CE. New clinical markers predictive of cardiovascular disease: the role of inflammatory mediators. Cardiology in Review. 2004; 12: 151–157.
Moisi MI, Bungau SG, Vesa CM, Diaconu CC, Behl T, Stoicescu M, et al. Framing Cause-Effect Relationship of Acute Coronary Syndrome in Patients with Chronic Kidney Disease. Diagnostics (Basel, Switzerland). 2021; 11: 1518.
Takata T, Sakasai-Sakai A, Ueda T, Takeuchi M. Intracellular toxic advanced glycation end-products in cardiomyocytes may cause cardiovascular disease. Scientific Reports. 2019; 9: 2121.
Published
How to Cite
Issue
Section
Copyright (c) 2024 The Author(s)
This work is licensed under a Creative Commons Attribution 4.0 International License.
